| 1 |
Fischer U, Baumgartner A, Arnold M, et al. What is a mi-nor stroke? [J]. Stroke, 2010, 41(04): 661-666.
|
| 2 |
Yi Ju, Xing-Quan Zhao, Chun-Xue Wang, et al. Neurological deterioration in the acute phase of minor ischemic stroke is an independent prediction of poor outcomes at 1 year: results from the China National Stroke Registry(CNSR) [J]. Chin Med J (Engl), 2013, 126(18): 3411-3416.
|
| 3 |
中国卒中学会指南编写组. 高危非致残性缺血性脑动脉事件诊疗指南2016 [J]. 中国卒中杂志, 2016, 11(06): 481-491.
|
| 4 |
Yongjun W, Yilong W, Xingquan Z, et al. Clopidogrel withaspirin in acute minor stroke or transient ischemic attack [J]. N Eng J Med, 2013, 369(01): 11-19.
|
| 5 |
Crespi V, Braga M, Beretta S, et al. A practical definition of minor stroke [J]. Neurological sciences, 2013, 34(07): 1083-1086.
|
| 6 |
Eggers CCJ, Bocksrucker C, Seyfang L, et al. The efficacy of thrombolysis in lacunar stroke - evidence from the austrian stroke unit registry [J]. Eur J Neurol, 2017, 24(06): 780-787.
|
| 7 |
Torres-Mozqeeda F, He J, Yeh IB, et al. An acute stroke classification instrument that includes CT or MR angiography The Boston Acute stroke imaging scake(BASIS) [J]. AJNR, 2008, 29(06): 1111-1117.
|
| 8 |
Lin J, Zheng H, Cucchiara BL, et al. Association of lp-pla2-a and early recurrence of vascular events after tia and minor stroke [J]. Neurology, 2015, 85(18): 1585-1591.
|
| 9 |
Akoudad S, Sedaghat S, Hofman A, et al. Kidney function and cerebral small vessel disease in the general population [J]. Int J Stroke, 2015, 10(04): 603-608.
|
| 10 |
Boehme AK, McClure LA, Zhang Y, et al. Inflammatory markers and outcomes after lacunar stroke: Levels of inflammatory markers in treatment of stroke study [J]. Stroke, 2016, 47(03): 659-667.
|
| 11 |
Zhou J, Zhang Y, Guo YJ, et al. A Study of Etiology Classification of Minor Stroke Based on TOAST and ASCO Systems [J]. Sichuan Da Xue Xue Bao Yi Xue Ban, 2017, 48(03): 493-496.
|
| 12 |
Khatri P, Conaway MR, Johnston KC, et al. Ninety-day outcome rates of a prospective cohort of consecutive patients with mild ischemic stroke [J]. Stroke, 2012, 43(02): 560-562.
|
| 13 |
Mantero V , Filizzolo M , Botto E, et al. Size,shape and location of lacunar strokes and correlation with risk factors [J].Clin Neurol Neurosurg, 2020 ,190: 105665.
|
| 14 |
短暂性脑缺血发作中国专家共识组. 短暂性脑缺血发作与轻型卒中抗血小板治疗中国专家共识(2014年) [J]. 中华医学杂志, 2014, 94(27): 2092-2096.
|
| 15 |
Coutts SB, Dubuc V, Mandzia J, et al. Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion [J]. Stroke, 2015, 46(03): 769-774.
|
| 16 |
Yeatts SD, Broderick JP, Chatterjee A, et al. Alteplase for the treatment of acute ischemic stroke in patients with low national institutes of health stroke scale and not clearly disabling deficits (potential of rtpa for ischemic strokes with mild symptoms prisms): Rationale and design [J]. Int J Stroke, 2018, 1747493018765269.
|
| 17 |
中国卒中学会科学声明专家组. 急性缺血性卒中静脉溶栓中国卒中学会科学声明 [J]. 中国卒中杂志, 2017, 12(03): 267-284.
|
| 18 |
Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the american heart association/american stroke association [J]. Stroke, 2018, 49(03): e46-e110.
|
| 19 |
Yongjun W, Yilong W, Xingquan Z, et al. Clopidogrel withaspirin in acute minor stroke or transient ischemic attack [J]. N Eng J Med, 2013, 369(01): 11-19.
|
| 20 |
Johnston SC, Easton JD, Farrant M, et al. Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA [J]. N Engl J Med, 2018, 379(03): 215-225.
|
| 21 |
Easton JD, Aunes M, Albers GW, et al. Risk for Major Bleeding in Patients Receiving Ticagrelor Compared with Aspirin After TIA or Acute Ischemic Stroke in the SOCRATES Study [J]. Circulation, 2017, 136(10): 907-916.
|
| 22 |
Wang Y, Lin Y, Meng X, et al. Effect of ticagrelor with clopidogrel on high on-treatment platelet reactivity in acute stroke or transient ischemic attack (PRINCE) trial: Rationale and design [J]. 2017, 12(03): 321-325.
|
| 23 |
Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS [J]. Eur Heart J, 2016, 37(38): 2893-2962.
|
| 24 |
Yang F, Lei H, Jiang W, et al. Initial 3-weeks’ ApixabanVersus Dual-antiplatelet Therapy ( Clopidogrel and Aspirin ) followed by Clopidogrel alone in high-risk patients with Acute Non-Disabling Cerebrovascular Events ( ADANCE ): studyprotocol for a randomized controlledtrial [J]. ClinDrug Investig, 2014, 34(11): 755-761.
|
| 25 |
Yang F, Jiang W, Bai Y, et al. Treatment of Rivaroxaban versus Aspirin for Non -disabling Cerebrovascular Events(TRACE): study protocol for a randomized controlled trial [J]. BMC Neurol, 2015, 15(195): 1-7.
|
| 26 |
Liang R, Li L, Li C, et al. Impact of CYP2C9*3, VKORC1-1639, CYP4F2rs2108622 genetic polymorphism and clinical factors on warfarin maintenance dose in Han-Chinese patients [J]. J Thromb Thrombolysis, 2012, 34(01): 120-125.
|
| 27 |
Da Silveira MMBM, Melo LA , Gomes FMF, et al. Polymorphisms of CYP2C9*2, CYP2C9*3 and VKORC1 genes related to time in therapeutic range in patients with atrial fibrillation using warfarin [J]. Appl Clin Genet, 2019, 12: 151-159.
|
| 28 |
Ling X, Yan SM, Shen B, et al. A modified Essen Stroke Risk Score for predicting recurrent ischemic stroke at one year [J]. Neurol Res, 2018, 40(03): 204-210.
|
| 29 |
Liu Y, Wang Y, Li WA, et al. Validation of the Essen Stroke Risk Score in different subtypes of ischemic stroke [J]. Neurol Res, 2017, 39(06): 504-508.
|
| 30 |
Liu J, Li M, Liu J. Evaluation of the ESRS and SPI-II scales for short-term prognosis of minor stroke and transient ischemic attack [J]. Neurol Res, 2013, 35(06): 568-572.
|
| 31 |
Knoflach M, Lang W, Seyfang L, et al. Predictive value of ABCD2 and ABCD3-I scores in TIA and minor stroke in the stroke unit setting [J]. Neurology, 2016, 87(09): 861-869.
|
| 32 |
Leira EC, Ludwig BR, Gurol ME, et al. The types of neurological deficits might not justify withholding treatment in patients with low total national institutes of health stroke scale scores [J]. Stroke, 2012, 43(03): 782-786.
|